A review of atypical antipsychotic medications for posttraumatic stress disorder

International Clinical Psychopharmacology

Volumn 26, Issue 4, 2011, Pages 193-200

  Ahearn, Eileen P ^a,b   Juergens, Timothy ^a,b   Cordesb, Timothy ^b   Becker, Tara ^c   Krahn, Dean ^a,b  

^a WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^b Departments of Psychiatry   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Atypical antipsychotics; Pharmacologic treatment; Posttraumatic stress disorder

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; FLUPHENAZINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; PLACEBO; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

BIBLIOGRAPHIC DATABASE; CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; DYSTONIA; EFFECT SIZE; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; HUMAN; INCREASED APPETITE; OPEN STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR ACTIVATION; PSYCHOMOTOR DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; TACHYCARDIA; THORAX PAIN; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; CONTROLLED CLINICAL TRIALS AS TOPIC; DIBENZOTHIAZEPINES; HUMANS; RISPERIDONE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 80051549125     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e3283473738     Document Type: Review

References (51)

1. Adityanjee Schulz SC (2002). Clinical use of quetiapine in disease states other than schizophrenia. J Clin Psychiatry 63 (Suppl 13):32-38.
2. Ahearn EP, Mussey M, Johnson C, Krohn A, Krahn D (2006). Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study. Int Clin Psychopharmacol 21:29-33. (Pubitemid 43175120)
3. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, and North American Association for the Study of Obesity (2004). Consensus Development Conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27: 596-601.
4. Bartzokis G, Freeman TW, Roca V (2002). Risperidone in the treatment of chronic combat-related posttraumatic stress disorder. CINP.
5. Bartzokis G, Lu PH, Turner J, Mintz J, Saunders CS (2005). Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry 57:474-479. (Pubitemid 40311981)
6. Beckham JC, Crawford AL, Feldman ME (1998). Trail making test performance in Vietnam combat veterans with and without posttraumatic stress disorder. J Trauma Stress 11:811-819. (Pubitemid 28565584)
7. Butterfield MI, Becker ME, Connor KM, Sutherland S, Churchill LE, Davidson JR (2001). Olanzapine in the treatment of post-traumatic stress disorder: a pilot study. Int Clin Psychopharmacol 16:197-203. (Pubitemid 32612517)
8. Calhoun PS, Bosworth HB, Grambow SC, Dudley TK, Beckham JC (2002). Medical service utilization by veterans seeking help for posttraumatic stress disorder. Am J Psychiatry 159:2081-2086. (Pubitemid 35423869)
9. Cohen BE (2010). Mental health diagnoses and utilization of VA non-mental health medical services among returning Iraq and Afghanistan veterans. J Gen Int Med 25:18-24.
10. David D, Kutcher GS, Jackson EI, Mellman TA (1999). Psychotic symptoms in combat-related posttraumatic stress disorder. J Clin Psychiatry 60:29-32. (Pubitemid 29069882)
11. David D, De Faria L, Lapeyra O, Mellman TA (2004). Adjunctive risperidone treatment in combat veterans with chronic PTSD J Clin Psychopharmacol 24:556-559. (Pubitemid 39274216)
12. Davidson JR (2004). Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD Scale. Int Clin Psychopharmacol 19:85-87. (Pubitemid 38316766)
13. Friedman MJ, Marmar CR, Baker DG, Sikes CR, Farfel GM (2007). Randomized double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a department of veterans affairs setting. J Clin Psychiatry 68: 711-720. (Pubitemid 46841854)
14. Gao K, Sheehan DV, Calabrese JR (2009). Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders. Expert Rev Neurother 9:1147-1158.
15. Haddad PM, Sharma SG (2007). Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs 21:911-936. (Pubitemid 47557106)
16. Hamner MB (1997). Psychotic features and combat-associated PTSD. Depress Anxiety 5:34-38. (Pubitemid 28106011)
17. Hamner MB, Gold PB (1998). Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder. Psychiatry Res 77:175-181. (Pubitemid 28157269)
18. Hamner MB, Frueh BC, Ulmer HG, Arana GW (1999). Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry 45:846-852. (Pubitemid 29185475)
19. Hamner MB, Frueh BC, Ulmer HG, Huber MG, Twomey TJ, Tyson C, Arana GW (2000). Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis 188:217-221. (Pubitemid 30210862)
20. Hamner MB, Faldowski RA, Ulmer HG, Frueh BC, Huber MG, Arana GW (2003a). Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol 18:1-8. (Pubitemid 36127054)
21. Hamner MB, Deitsch SE, Brodrick PS, Ulmer HG, Lorberbaum JP (2003b). Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol 23:15-20. (Pubitemid 36164420)
22. Hamner MB, Canive J, Robert S, Calais LA, Villarreal G, Durkalski V (2009). Quetiapine monotherapy in chronic posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial. APA Meeting.
23. Hertzberg MA, Feldman ME, Beckham JC, Kudler HS, Davidson JR (2000). Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans. Ann Clin Psychiatry 12:101-105. (Pubitemid 30470156)
24. Ivezic S, Bagaric A, Oruc L, Mimica N, Ljubin T (2000). Psychotic symptoms and comorbid psychiatric disorders in Croatian combat-related posttraumatic stress disorder patients. Croat Med J 41:179-183. (Pubitemid 30411791)
25. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB (1995). Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 52:1048-1060.
26. Kodama M, Fujioka T, Duman RS (2004). Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56:570-580. (Pubitemid 39336404)
27. Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO (2005). Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry 66:922-927. (Pubitemid 41032835)
28. Krystal JH, Neumeister A (2009). Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Res 1293:13-23.
29. Monnelly EP, Ciraulo DA, Knapp C, Keane T (2003). Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder. J Clin Psychopharmacol 23:193-196. (Pubitemid 36368797)
30. Nemeroff CB (2005). Use of atypical antipsychotics in refractory depression and anxiety. J Clin Psychiatry 66 (Suppl 8):13-21. (Pubitemid 43004171)
31. Padala PR, Madison J, Monnahan M, Marcil W, Price P, Ramaswamy S, et al. (2006). Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women. Int Clin Psychopharmacol 21:275-280. (Pubitemid 44162479)
32. Pae CU, Lim HK, Peindl K, Ajwani N, Serretti A, Patkar AA, Lee C (2008). The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol 23:1-8. (Pubitemid 350294864)
33. Petty F, Brannan S, Casada J, Davis LL, Gajewski V, Kramer GL, et al. (2001). Olanzapine treatment for post-traumatic stress disorder: an open-label study. Int Clin Psychopharmacol 16:331-337. (Pubitemid 33030048)
34. Pivac N, Kozaric-Kovacic D, Muck-Seler D (2004). Olanzapine versus fluphenazine in an open trial in patients with psychotic combat-related post-traumatic stress disorder. Psychopharmacology (Berl) 175:451-456. (Pubitemid 39362043)
35. Rao S, Zisook S (2009). Anxious depression: clinical features and treatment. Curr Psychiatry Rep 11:429-436.
36. Raskind MS (2009). Pharmacologic treatment of posttraumatic stress disorder. In: Shiromani PJ, Keane TM, LeDoux JE, editors. Post traumatic stress disorder. NY: Humana Press. pp. 337-361.
37. Reich DB, Winternitz S, Hennen J, Watts T, Stanculescu C (2004). A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women. J Clin Psychiatry 65:1601-1606.
38. Robert S, Hamner MB, Kose S, Ulmer HG, Deitsch SE, Lorberbaum JP (2005). Quetiapine improves sleep disturbances in combat veterans with PTSD: sleep data from a prospective, open-label study. J Clin Psychopharmacol 25:387-388. (Pubitemid 41060262)
39. Robert S, Hamner MB, Durkalski VL, Brown MW, Ulmer HG (2009). An openlabel assessment of aripiprazole in the treatment of PTSD Psychopharmacol Bull 42:69-80.
40. Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH (2008). Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry 69:520-525. (Pubitemid 351792325)
41. Stein MB, Kline NA, Matloff JL (2002). Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 159:1777-1779.
42. Stein DJ, Ipser JC, Seedat S (2006). Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 25:CD002795.
43. Thase ME (2002). What role do atypical antipsychotic drugs have in treatmentresistant depression? J Clin Psychiatry 63:95-103. (Pubitemid 34173844)
44. US Department of Health and Human Services: depression guideline panel (1993) Clinical practice guidelines no 5. depression in primary care.
45. Van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, Saxe G (1994). Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55:517-522.
46. Vasterling JJ, Duke LM, Brailey K, Constans JI, Allain AN Jr, Sutker PB (2002). Attention, learning, and memory performances and intellectual resources in Vietnam veterans: PTSD and no disorder comparisons. Neuropsychology 16:5-14. (Pubitemid 34132153)
47. Vermetten E, Bremner JD (2002). Circuits and systems in stress. II applications to neurobiology and treatment in posttraumatic stress disorder. Depress Anxiety 16:14-38. (Pubitemid 34977121)
48. Wakade CG, Mahadik SP, Waller JL, Chiu FC (2002). Atypical neuroleptics stimulate neurogenesis in adult rat brain. J Neurosci Res 69:72-79. (Pubitemid 34734166)
49. Wang HD, Dunnavant FD, Jarman T, Deutch AY (2004). Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology 29:1230-1238. (Pubitemid 38780646)
50. Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group (2009). Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebocontrolled study. CNS Spectr 14:299-313.
51. Zohar J, Amital D, Miodownik C, Kotler M, Bleich A, Lane RM, Austin C (2002). Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol 22:190-195. (Pubitemid 34289394)